Effect of Serum Containing Sarcandrae Compound on Proliferation, Telomerase Activity and Cellular Apoptosis of HepG2 Cells

您当前的位置：

首页 >

文章列表页 >

Effect of Serum Containing Sarcandrae Compound on Proliferation, Telomerase Activity and Cellular Apoptosis of HepG2 Cells

更新时间：2024-01-04

- Effect of Serum Containing Sarcandrae Compound on Proliferation, Telomerase Activity and Cellular Apoptosis of HepG2 Cells
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 2, Pages: 109-112(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2014020109
  CLC：
- Published：2014
- 稿件说明：
移动端阅览
ZHU Xiao-ying, LI Tao, LI Sheng-yi, et al. Effect of Serum Containing Sarcandrae Compound on Proliferation, Telomerase Activity and Cellular Apoptosis of HepG2 Cells[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(2): 109-112.
DOI：

ZHU Xiao-ying, LI Tao, LI Sheng-yi, et al. Effect of Serum Containing Sarcandrae Compound on Proliferation, Telomerase Activity and Cellular Apoptosis of HepG2 Cells[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(2): 109-112. DOI： 10.11653/syfj2014020109.

摘要

目的：观察肿节风复方含药血清对人肝癌细胞HepG2细胞增殖及凋亡的影响。方法：实验设阴性对照组（NS）、5-氟尿嘧啶（5-FU）组（0.025 g·kg-1）和肿节风复方低、中、高剂量组（2.5，5，10 g·kg-1），灌服于大鼠后，提取含药血清。取上述含药血清分别作用于HepG2细胞24，48，72 h；MTT法测定细胞增殖抑制率；ELISA法测定端粒酶活性；荧光显微法及流式细胞术（Annexin V-FITC/PI法）检测肿节风复方含药血清对HepG2细胞凋亡的影响。结果：与对照组比较，肿节风复方含药血清低、中、高剂量组均能抑制HepG2细胞的增殖（高剂量组抑制率最高达42.5%），呈现与时间-剂量依赖趋势；肿节风中、高剂量组能有效抑制HepG2细胞端粒酶活性，与对照组比较P < 0.05；肿节风复方含药血清具有诱导HepG2细胞凋亡的作用，与对照组比较P < 0.05，其中中剂量组作用24，48，72 h细胞凋亡率分别为（14.2±0.9）%，（30.6±1.0）%，（61.6±1.5）%。结论：肿节风复方含药血清能抑制HepG2细胞增殖、端粒酶活性，诱导HepG2细胞凋亡。

Abstract

Objective: To investigate effect of serum containing Sarcandrae compound on proliferation

telomerase activity and cellular apoptosis of HepG2 liver cancer cells. Method: Serum containing drugs was prepared by Administration of physiological saline

different concentrations of Sarcandrae compound and 5-fluoro-2

4(1H

3H)pyrimidinedion(5-FU). Consequently to rats. The serum containing drugswas used totreat HepG2 cells for 24

48

72 h. Then the effects of different drugs on proliferation

telomerase and apoptosis of HepG2 cells were observed by MTT

ELISA and Flow cytometry Annexin V-FITC/PI assay

respectively. Result: Compared to control group

proliferation and telomerase activities of HepG2 cells were inhibited with time-dependent manner by serum containing Sarcandrae compound significantly (P<0.05). All serum containing Sarcandrae compound could promote the apoptosis of HepG2 cells significantly. For middle dose group at 24

48

72 h the apoptosis rate was (14.2±0.9)%

(30.6±1.0)%

(61.6±1.5)%. Conclusion: Serum containing Sarcandrae compound can inhibit the proliferation and telomerase activity of HepG2 cells

and promote the apoptosis of HepG2 cells.

关键词

Keywords

references

0

Views

4

下载量

0

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Related Articles

Effect of Salidroside on Proliferation， Migration， Invasion， and Apoptosis of HepG2 Cells

Effect of Jiawei Sijunzi Decoction Containing Serum on B16 Malignant Melanoma Cell Proliferation and Apoptosis

Treatment of Sepsis-induced Inflammatory Responses with Xijiao Dihuangtang by Modulation of PKM2-mediated One-carbon Metabolism Pathway

Mitochondrial Quality Control Regulating Pathogenesis of Sarcopenia and Its Intervention by Traditional Chinese Medicine： A Review

Mechanism of Modified Danggui Shaoyaosan in Improving Inflammation and Apoptosis in Acne via Regulating JNK/p38 MAPK Pathway

Related Author

Bing JIANG

Tao YANG

Longfei FENG

Tao WANG

Haixiang SU

ZHOU Xin-xin

WANG Cai-xia

YAN Qixiang

Related Institution

Gansu University of Chinese Medicine

Gansu Provincial Academic Institute for Medical Research， Gansu Provincial Cancer Hospital

Affiliated Hospital of Nanjing University of Chinese Medicine

The First Clinical Medical College，Nanjing University of Chinese Medicine

Jiangsu Province Hospital of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰